Drug Type Small molecule drug |
Synonyms G 7453 |
Target |
Action antagonists |
Mechanism GP IIb/IIIa antagonists(Integrin alpha-IIb/beta-3 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H18N8O4 |
InChIKeySXAVWARGHMNBCH-UHFFFAOYSA-N |
CAS Registry167854-60-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Thrombosis | Phase 1 | United States | - | - |
| Thrombosis | Phase 1 | Switzerland | - | - |
| Thrombosis | Phase 1 | - | - |





